We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.89%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$930M
Cap. Flow %
1.62%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.89%
2 Technology 9.94%
3 Financials 9.11%
4 Healthcare 8.75%
5 Industrials 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOO icon
1
Vanguard S&P 500 ETF
VOO
$1.05T
$2.8B 4.88%
12,177,642
+375,705
+3% +$93.1M
AGG icon
2
iShares Core US Aggregate Bond ETF
AGG
$138B
$2.31B 4.02%
21,696,335
+154,671
+0.7% +$16.2M
IEFA icon
3
iShares Core MSCI EAFE ETF
IEFA
$197B
$2.09B 3.63%
37,931,197
+1,291,769
+4% +$75.8M
MSFT icon
4
Microsoft
MSFT
$3.71T
$931M 1.62%
9,165,580
+284,737
+3% +$30.5M
SPY icon
5
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$881M 1.54%
3,526,655
+1,365,461
+63% +$368M
AAPL icon
6
Apple
AAPL
$4.67T
$818M 1.43%
20,754,144
-536,860
-3% -$26M
USMV icon
7
iShares MSCI USA Min Vol Factor ETF
USMV
$24.1B
$726M 1.26%
13,849,934
+557,387
+4% +$30.6M
JPM icon
8
JPMorgan Chase
JPM
$953B
$572M 1%
5,857,534
+123,988
+2% +$13.2M
AMZN icon
9
Amazon
AMZN
$2.79T
$567M 0.99%
7,545,640
+528,920
+8% +$44M
VZ icon
10
Verizon
VZ
$208B
$536M 0.93%
9,533,607
+88,993
+0.9% +$5.05M
IWF icon
11
iShares Russell 1000 Growth ETF
IWF
$126B
$530M 0.92%
16,183,268
+1,680,136
+12% +$59.2M
CSCO icon
12
Cisco
CSCO
$431B
$522M 0.91%
12,054,624
+2,854,402
+31% +$131M
IWD icon
13
iShares Russell 1000 Value ETF
IWD
$84.1B
$465M 0.81%
4,189,496
+727,974
+21% +$87.2M
CVX icon
14
Chevron
CVX
$409B
$459M 0.8%
4,218,539
+245,281
+6% +$28.4M
JNJ icon
15
Johnson & Johnson
JNJ
$663B
$457M 0.8%
3,542,148
+102,193
+3% +$14.3M
IJR icon
16
iShares Core S&P Small-Cap ETF
IJR
$110B
$445M 0.78%
6,424,539
+56,633
+0.9% +$4.38M
PFE icon
17
Pfizer
PFE
$162B
$443M 0.77%
10,705,363
-774,060
-7% -$32.1M
IJH icon
18
iShares Core S&P Mid-Cap ETF
IJH
$126B
$420M 0.73%
12,656,345
+434,305
+4% +$15.8M
MRK icon
19
Merck
MRK
$371B
$417M 0.73%
5,718,195
+150,816
+3% +$10.6M
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.08T
$382M 0.66%
1,868,674
+182,015
+11% +$38M
HD icon
21
Home Depot
HD
$320B
$374M 0.65%
2,174,738
+58,651
+3% +$10.5M
ABBV icon
22
AbbVie
ABBV
$453B
$369M 0.64%
4,007,944
+472,550
+13% +$41.6M
IEMG icon
23
iShares Core MSCI Emerging Markets ETF
IEMG
$165B
$368M 0.64%
7,811,039
+237,201
+3% +$11.5M
SDY icon
24
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$364M 0.63%
4,063,579
+231,015
+6% +$21.8M
UNH icon
25
UnitedHealth
UNH
$356B
$352M 0.61%
1,413,965
-56,254
-4% -$14.9M

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 36% a quarter earlier, followed by Technology and Financials.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.